T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Editas Medicine
EDIT
$230M
| $222K | ﹤0.01% |
64,818
+12,363
| +24% | +$42.3K |
|
2602
UWM Holdings
UWMC
$1.49B
| $222K | ﹤0.01% |
25,953
+3,132
| +14% | +$26.8K |
|
2603
Miller Industries
MLR
$454M
| $221K | ﹤0.01% |
+3,615
| New | +$221K |
|
2604
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.6B
| $221K | ﹤0.01% |
1,100
| – | – |
|
2605
Canterbury Park Holding Corp
CPHC
$84.8M
| $220K | ﹤0.01% |
11,379
| – | – |
|
2606
DXP Enterprises
DXPE
$1.79B
| $220K | ﹤0.01% |
+4,115
| New | +$220K |
|
2607
Horizon Bancorp
HBNC
$839M
| $220K | ﹤0.01% |
14,085
+372
| +3% | +$5.81K |
|
2608
Seaboard Corp
SEB
$3.72B
| $220K | ﹤0.01% |
+70
| New | +$220K |
|
2609
ArriVent BioPharma
AVBP
$766M
| $220K | ﹤0.01% |
+9,345
| New | +$220K |
|
2610
Cytek Biosciences
CTKB
$476M
| $219K | ﹤0.01% |
39,503
+1,176
| +3% | +$6.52K |
|
2611
SPDR Gold Trust
GLD
$115B
| $219K | ﹤0.01% |
+900
| New | +$219K |
|
2612
Veritone
VERI
$201M
| $218K | ﹤0.01% |
60,500
| – | – |
|
2613
Asure Software
ASUR
$219M
| $217K | ﹤0.01% |
23,960
+348
| +1% | +$3.15K |
|
|
BBUC
2614
Brookfield Business Corp
BBUC
$2.36B
| $217K | ﹤0.01% |
+8,533
| New | +$217K |
|
2615
Orrstown Financial Services
ORRF
$681M
| $217K | ﹤0.01% |
+6,015
| New | +$217K |
|
2616
indie Semiconductor
INDI
$790M
| $216K | ﹤0.01% |
53,904
+1,715
| +3% | +$6.87K |
|
2617
Kelly Services Class A
KELYA
$465M
| $216K | ﹤0.01% |
10,085
+319
| +3% | +$6.83K |
|
2618
Klaviyo
KVYO
$9.35B
| $216K | ﹤0.01% |
+6,079
| New | +$216K |
|
2619
Dianthus Therapeutics
DNTH
$1.22B
| $215K | ﹤0.01% |
+7,821
| New | +$215K |
|
2620
SIGA Technologies
SIGA
$624M
| $215K | ﹤0.01% |
31,715
+1,278
| +4% | +$8.66K |
|
2621
Avita Medical
RCEL
$113M
| $213K | ﹤0.01% |
19,800
-255
| -1% | -$2.74K |
|
2622
Atlanticus Holdings
ATLC
$1.02B
| $211K | ﹤0.01% |
+6,011
| New | +$211K |
|
2623
Golden Entertainment
GDEN
$634M
| $210K | ﹤0.01% |
6,593
+185
| +3% | +$5.89K |
|
2624
Blink Charging
BLNK
$129M
| $207K | ﹤0.01% |
120,022
+26,700
| +29% | +$46K |
|
2625
Cricut
CRCT
$1.33B
| $207K | ﹤0.01% |
29,784
+1,776
| +6% | +$12.3K |
|